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8 ABSTRACT: State-of-the-art high-resolution separation tech-
9 niques play an important role in the full structural elucidation
10 of glycans. Capillary electrophoresis (CE) oﬀers a rapid yet
11 simple method for exhaustive carbohydrate proﬁling. CE is a
12 versatile analytical platform, which can be operated in several
13 separation modes, simply by altering separation conditions
14 during operation. For in-depth glycan structural analysis, CE
15 has also gained signiﬁcantly from the additional resolution
16 introduced by complementary and orthogonal separation
17 techniques such as ion exchange or hydrophilic interaction
18 chromatography. Commercially available mass spectrometry (MS) interfaces have not only brought this information-rich
19 detection technique within reach, but CE also represents an expedient highly eﬃcient separation inlet for MS, capable of
20 separating isobaric oligosaccharide isomers prior to MS detection and MS/MS fragmentation based identiﬁcation. This
21 Perspective gives a sophisticated impression of the versatility of capillary electrophoresis for deep structural elucidation of
22 carbohydrates derived from glycoproteins of biomedical interest. Diﬀerent separation modes for the analysis of both charged and
23 neutral glycans, such as inﬂuencing electroosmotic ﬂow, using complexation/interaction based secondary equilibria, and the use
24 of charged and neutral labels are compared. The merits of introducing orthogonal and complementary techniques, such as
25 exoglycosidase digestion arrays, analytical/preparative chromatography and mass spectrometric detection, and extending the
26 dynamic range and resolution of CE are all thoroughly discussed.
27 The structural elucidation of protein derived glycosylation,28 which may possess vast structural diversity including
29 positional and/or linkage isomerism, poses a substantial
30 analytical challenge. The discovery of diﬀerent glycan moieties’
31 involvement in protein conﬁrmation or function, cell−cell
32 signaling, and reﬂection of cellular or even organism
33 physiological state has attracted major research attention.
34 Because of the analytical complexity associated with glyco-
35 sylation analysis, a variety of orthogonal analytical techniques is
36 used, often in combined fashion, and generally including
37 separation driven methods combined with optical, chemical, or
38 mass selective detection.1 Capillary electrophoresis (CE) today
39 is an important tool in unraveling the glyco-puzzle and
40 represents a rapid yet highly resolving analytical platform.
41 In the current discerning Perspective of the structural
42 elucidation potential of capillary electrophoresis in analyzing
43 complex protein derived carbohydrates of biomedical and
44 biopharmaceutical interest is presented. Auxiliary techniques,
45 such as sequential exoglycosidase digestion, lectin aﬃnity
46 partitioning, analytical/preparative chromatography and mass
47 spectrometry (MS) detection in conjunction with tandem mass
48 spectrometry (MS/MS) fragmentation are discussed based
49 upon their structural identiﬁcation capabilities when interfaced
50 with CE.
51■ TECHNICAL OVERVIEW
52The technical simplicity of capillary electrophoresis can be
53deceptive; CE is a highly adaptive versatile technique, enabling
54several separation modes simply by altering the separation
55conditions such as the background electrolyte used. Controlling
56the electroosmotic ﬂow (EOF) phenomenon, that is the
57directional bulk ﬂow generated under an electric ﬁeld by ions
58attracted to capillary surface charges and its direction (co- or
59counter-electrophoretic mobility, μe), allows altering the
60migration time window and the experimental run time. EOF
61toward the detection site facilitates a stable liquid ﬂow and CE
62current for electrospray ionization (ESI) with hyphenated mass
63spectrometric detection2 or can generate a reverse migration
64order3,4 when driving against analyte electrophoretic mobilities
65(with μEOF > μe). Suppression of the EOF by covalent or
66dynamic coating of surface charges can remarkably elevate
67experimental reproducibility. Under arheic (without ﬂow)
68conditions, capillary zone electrophoresis (CZE) separates
69analytes based on their charge to hydrodynamic volume ratio
70diﬀerences thus rendering it a powerful tool for carbohydrate
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71 isomer identiﬁcation. The selectivity of CE for the separation of
72 similar oligosaccharides can be improved by introducing
73 secondary equilibria, such as borate complexation,5 micellar
74 surfactants,6−9 chromatographic (pseudo-) stationary phases,10
75 or by polymeric additives.11
76 Protein derived carbohydrates from physiological samples are
77 often only available in limited quantities, lack chromophores or
78 ﬂuorophores, and frequently contain diﬀerentially charged
79 species. Therefore, derivatization with charged ﬂuorogenic
80 agents is a popular means to increase detector sensitivity and
81 enable the simultaneous separation of neutral and charged
82 analytes using electric ﬁeld mediated methods. While optical
83 on-column detection techniques such as laser induced
84 ﬂuorescence (LIF) enable high sensitivity and selectivity they
85 do not however, provide additional glycan structural
86 information. The choice of a labeling agent is strongly
87 dependent on the application and needs to be carefully
88 selected according to the background electrolyte (BGE), EOF,
89 sample characteristics, and also the detection method.
90 Enzymatically released N-linked glycans by peptide-N4-(N-
91 acetyl-β-glucosaminyl)asparagine amidase (PNGase F) main-
92 tain the free amino group from the side chain of the parent
93 asparagine and the resulting glycosylamine can be derivatized
94 with amine reactive dyes under basic conditions.12,13 More
95 commonly, the liberated glycosylamines are converted to
96 reducing sugars (aldehyde form) at acidic pH and reacted
97 with primary amino group containing dyes via reductive
98 amination.14−16 However, low pH and high temperatures can
99 promote analyte hydrolysis and the potential loss of labile
100 glycan constituents as well as selective labeling need to be
101 diligently precluded by optimizing the derivatization reac-
102 tion.17,18 A favorable derivatization agent not only needs to
103 meet reaction chemistry, size, and pH stable charge state
104 requirements but also has to be compatible with the available
105 detection platforms (e.g., laser excitation wavelength). On-
106 column complexation,19 EOF, or charged residues (e.g., sialic
107 acids) can also provide suﬃcient separation mobility. Under-
108 ivatized glycans are disadvantageous for sensitive optical
109 detection but are commonly applied in mass spectrometric
110 analysis.20 A free reducing end enhances MS fragmentation
111 options but may also increase analyte complexity due to
112 anomericity.21 Conjugated glycans potentially reach higher
113 ionization yields.15,22
114 The transition to online mass detection techniques with
115 electrospray ionization brings about the necessity to alter CE
116 separation conditions, including replacement of outlet buﬀer
117 reservoir and associated electrical circuit closing as well as
118 introducing volatile background electrolytes, to achieve MS
119 compatibility. Key for successful hyphenation of CE and MS are
120 interfaces that produce a stable spray with low ﬂow (preferably
121 <20 nL/min) and allow nearly independent optimization of the
122 separation and ionization sections. Although, a certain degree of
123 compromise needs to be accepted: popular sheath ﬂow
124 interfaces use a sheath liquid at the capillary outlet, which
125 can be optimized for stable ionization but at the cost of
126 sensitivity due to sample dilution. Direct or sheathless
127 connections generally incorporate low ﬂow rates, high
128 sensitivity, and reduced ion suppression, but a common BGE
129 for reasonable separation performance and ionization yield
130 needs to be found. Liquid junction interfaces introduce a liquid
131 lined gap between the separation capillary and ionization source
132 that allows decoupling optimization of CE separation and ESI
133 parameters at low sample dilution eﬀects. In-depth information
134about CE−MS technology, including glycan analysis using oﬀ-
135line interfacing and further ionization techniques such as
136matrix-assisted laser desorption/ionization (MALDI), can be
137obtained from eminent recent review articles.20,23−25
138Miniaturization of CE into microchannels devices oﬀers
139another attractive ESI-MS front end due to high sensitivity
140analysis of nanoliter amounts of sample.26 Irrespective of the
141chosen detection method, microchannel glycan separations
142generally oﬀer ultra fast separation times on the seconds scale
143but usually at the cost of resolution; particularly of glycans
144carrying additional charged constituents, which are often
145removed prior to analysis.27−29 For fast screening, e.g., of
146mAb glycans during clone selection or rapid proﬁling of clinical
147samples in disposable chips, where throughput is decisive, a
148lower separation eﬃciency can be acceptable. Moreover, recent
149introduction of longer separation channels has converged CE
150and microchannel CE eﬃciencies but such designs yet need to
151be commercialized.30−32
152A dramatic gain in throughput is also possible by simply
153running multiple separation columns in parallel. Multiplexed
154systems are commercially available and incorporate from 4 up
155to 96 capillaries. High experimental precision is maintained by
156coinjection of internal standards for alignment. Multicapillary
157systems are becoming increasingly established in clinical trials
158and biomarker discovery studies, where hundreds of samples
159are screened.33,34 However, commonly built-in electrokinetic
160injection systems require careful sample handling, such as
161maintaining consistent salt or free dye content.35 Avoiding
162selective analyte injection is of utmost importance when peak
163area based quantitation and associated statistical analyses are
164conducted.
165■ GLYCAN STRUCTURE ELUCIDATION
166CE oﬀers a variety of separation modes, which incorporate
167diﬀerent selectivity and associated glycan structure identiﬁca-
168tion potential. Counter-electroosmotic ﬂow enables increasing
169charge based migration grouping with respective larger species
170migrating prior to smaller ones of the same net charge.36
171Selectivity enhancement of structurally related glycan pools can
172be achieved by online interaction with ionic buﬀer additives,
173exhibiting diﬀerent complexation aﬃnity based upon mono-
174saccharide composition.37 Zone electrophoresis in aqueous or
175low viscosity polymer matrix with suppressed EOF provides
176exceptionally high resolution of isomeric species due to the
177separation principle of charge-to-hydrodynamic volume diﬀer-
178ences.38
179Oligosaccharide Standards. Co-injection of puriﬁed
180glycan standards with an unknown sample mixture poses a
181simple and eﬀective way for structural assignment. Although,
182basic knowledge about the nature of the analyte pool present is
183useful, because glycans with diﬀerent monosaccharide or
184linkage patterns can exhibit identical migration behavior.
185Limited commercial availability of structures, their production
186via puriﬁcation with techniques oﬀering restricted separation
187eﬃciency (e.g., isomers), and taxonomy mismatch with the
188sample further restrict practical implementation of standards.
189Anticipation of molecular size from analyte migration time
190can be achieved by the ancillary separation of gradually sized
191oligomeric sugar standards. Optimal reference standards
192incorporate equally distributed oligosaccharide pools exhibiting
193a linear relationship between size and migration time. Thus,
194linear homooligosaccharide ladders with degrees of polymer-
195ization (DP) 1, 2, ..., n of glucose(α1→ 4 or 6)n, glucose(β1→
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196 4)n, and N-acetylglucosamine(β1 → 4)n, produced by hydro-
197 lyzing starch, cellulose, and chitin-type polysaccharide chains,
198 respectively, are commonly applied standards. Hydrolysates of
199 branched structures, e.g., high-mannose type glycans,39 are
200 generally not recommended due to the occurrence of positional
201 isomers and the limited DP range. Molecular size standards can
202 either be coinjected with the sample, e.g., oligomer fragments of
203 DNA base pairs in multicapillary sequencer studies,40 or
204 analyzed in a separate experimental run, where alignment
205 standards are usually introduced in both sample and standard
f1 206 runs.41,42 Figure 1a,b shows the separation of a glucose-
207 oligomer ladder and a puriﬁed glycan standard, respectively.
208 The respective DP or sugar units (SU) of a sample peak can
209 be obtained by interpolation between adjacent oligosaccharide
210 ladder peaks or polynomial ﬁtting of multiple standard peaks.44
211 The conversion from migration time to a size-based scale of SU
212 also promotes interexperiment, -instrument, and -institution
213 precision and comparability, by compensating for potential
214 buﬀer composition, separation temperature, or column history
215 induced experimental deviations. The accumulation of SU
216 values of glycans with known (e.g., puriﬁed standards) or
217 decoded structural identity can evolve into the establishment of
218 a database, capable of decisively supporting structural
219 elucidation or denovo sequencing of unknown glycan pools.
220Usage of such databases requires consistent experimental
221conditions to those under which the data was generated,
222including the appropriate ladder standard. Glucose units (GU),
223i.e., SU based upon glucose oligomers, are widely used
224normalization standards in glycan analysis. Maltooligosacchar-
225ides (α1 → 4 linked oligo-glucoses) are the prevalently used
226standards in CE, whereas α1 → 6 linked isomaltooligsacchar-
227ides (also referred to as dextran) are predominantly applied in
228glycan analysis by hydrophilic interaction liquid chromatog-
229raphy (HILIC). Sole discrepancy in glycosidic linkage type or
230anomericity of oligosaccharides can impact their hydrodynamic
231volumes and result in diﬀerential migration, thus render SU
232based structural assignments inaccurate if mismatching stand-
233ards are used.44
234Enzymatic Digests. The speciﬁc cleavage of monosacchar-
235ide constituents from nonreducing termini via exoglycosidase
236enzymatic digestion represents another powerful means for
237glycan structure characterization. Depending on enzyme
238speciﬁcity, monosaccharide type, sequence, or even linkage
239and anomericity can be obtained when digest induced
240structural/shape changes are accompanied by CE monitoring.
241Sophisticated digest cascades can also lead to the identiﬁcation
242of positional isomers.45,46 Exoglycosidase digest arrays can
243either be conducted in parallel, where the sample is evenly split
Figure 1. Exoglycosidase sequencing of a puriﬁed biantennary core fucosylated complex glycan standard with a bisecting N-acetylglucosamine. (a)
Separation of an 8-aminopyrene-1,3,6-trisulphonic acid (APTS)-labeled oligomaltose hydrolysate reference standard. The number of glucose units
(DP, degree of polymerization) in these structures is indicated. (b) Nondigested standard. Standard digested with (c) β-galactosidase, (d) β-N-
acetylhexosaminidase, and (e) α-fucosidase. Standard digested simultaneously with (f) β-galactosidase and α-fucosidase, (g) β-galactosidase, β-N-
acetylhexosaminidase, and α-fucosidase. Symbols used for glycans are those suggested by the Consortium for Functional Glycomics. Reprinted with
permission from ref 43. Copyright 2006 Nature Publishing Group.
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244 into one aliquot per enzyme mixture, or in sequential fashion
245 using analysis-digest iterations of the same sample. Sequential
246 processing requires lower amounts of sample and enzymes and
247 takes advantage of the minimal injection volumes needed for
248 CE analysis. The use of nonvolatile buﬀer components or
249 addition of alignment standards to the sample prior to
250 injection, as for example used in multicapillary sequencer
251 experiments, can impede further digestion steps. Moreover,
252 exoglycosidase digests can cause changes in the sample ionic
253 strength or pH, introduced by salts of the digestion buﬀer, and
254 promote diﬀusion induced peak distortion as well as potentially
255 altered electrokinetic injection behavior.47 Volatile digestion
256 buﬀer systems are therefore generally recommended to alleviate
257 this issue. Most commercial enzymes are, however, supplied in
258 nonvolatile media and consequently will cause the described
259 problems in CE, if concentrated sample volumes or multiple
260 enzymes are used.
261 Exoglycosidase digestion of glycans with known structure
262 (e.g., puriﬁed standards) can cause a predictable loss of
263 constituents corresponding to enzyme speciﬁcity. After
264 reanalyzing the digested product by CE, glycan structural
265 diﬀerences can be recorded by the diﬀerences in migration time
266 and relative peak area compared to the substrate. Such shifts in
267 migration time, or respective sugar units, can be used to build a
268 knowledge base of monosaccharide residues and associated
269 “contributions”.48 Traces c and d and e and g in Figure 1
270 exemplify two diﬀerent digest cascade possibilities of the
271 puriﬁed glycan standard analyzed in trace b. Structural identity
272 of hydrolyzed products, respective SU, as well as digest induced
273 shifts can readily be deduced. Additionally, positions of
274 unknowns, e.g., a monogalactosylated biantennary species, can
275 be anticipated half way between the bi- and the agalactosylated
276 peaks as, respectively, depicted in Figure 1b,c.
277 In the case of dealing with unknown glycan mixtures,
278 increasing structural identity conﬁdence can be gained by
279 tracing respective peaks through several digestion steps or by
280 virtual “reattachment” of constituents in a bottom-up manner,
281 especially when combined with sugar unit shift analysis and CE-
282 based glycan structure reference databases. Relative peak areas
283 before and after digestion nevertheless need to be rationally
284 compared when analyzing complex oligosaccharide pools.
285 Glycans composed of diﬀerent monosaccharide units can
286 exhibit identical migration, due to, e.g., similar charge to
287 hydrodynamic volume properties but diﬀerentially or even
288 unaﬀected enzymatic digest reactivity. This can be either due to
289 lacking the epitope that matches enzyme substrate speciﬁcity or
290 inaccessibility potentially induced by steric hindrance. For
291 example the removal of bisecting N-acetylglucosamine
292 (GlcNAc) residues upon hexosaminidase treatment can be
293 hampered as depicted in Figure 1d,g.
294 The hydrolysis of sialic acids, which introduces additional
295 molecular charges, by sialidase treatment prior to analysis, is a
296 rather regularly applied practice in CE based glycan
297 investigations.29,33,34,49−52 However, associating sialic acid
298 removal with technical limitations of electromigration based
299 methods is a misapprehension. For example, CZE with
300 suppressed EOF oﬀered superior separation eﬃciency of
301 additionally charged thus faster migrating glycans, also when
302 compared with HILIC methods, due to decreased analyte
303 diﬀusion.53 The removal of sialic acids generally results in
304 decisive reduction of CE proﬁle complexity, by merging
305 previously distributed corresponding species with a diﬀerential
306 degree of sialylation as well as sialic acid linkage and positional
307isomers. This reduction of complexity coincides with the loss of
308information and potentially correlated physiological features,
309when investigating glycans of biomedical interest.54,55
310Although, the combination of previously distributed low
311abundant species upon sialidase digestion might also allow
312for the investigation of other biologically important glycan
313features, formerly undetected due to dynamic range issues.
314When electrokinetic injection is used, equalizing analyte charge
315states will also support diminishing potentially biased injection.
316Diﬀerent endoglycosidases, used for the release of aspar-
317agine-linked sugar moieties from glycoproteins, can be applied
318for speciﬁc glycan type-based partitioning. While PNGase F
319liberates all classes of N-linked glycans from mammalian
320glycoproteins, Endo-β-N-acetylglucosaminidase H (Endo H)
321speciﬁcally releases high-mannose and hybrid type oligosac-
322charides.56 Endo H cleaves substrate glycans between the two
323GlcNAc residues in the core region and readily enables the
324identiﬁcation of the speciﬁc glycan types by CE.57 Determi-
325nation of the intersection and diﬀerence sets with the respective
326PNGase F released pool enables type-based classiﬁcation,58,59
327when the alterations by the missing GlcNAc residue and
328associated SU shifts are accounted for.
329Exoglycosidase digests are usually carried out in low reaction
330volumes (∼10 μL) with overnight incubation to achieve
331exhaustive enzymatic processing. On-column enzymatic
332digestions represent a practical rapid, low sample, and enzyme
333consuming alternative with incubation times down to only a
334few minutes or even during the separation process itself by
335passing the injected sample through an enzyme plug.60 Direct
336introduction of exoglycosidases into narrow bore separation
337channels can increase enzymatic reaction speed due to
338decreased diﬀusion limitations, but such endeavors are
339sometimes incompatible with certain enzymes60 and often
340accompanied by some loss in separation eﬃciency.51,61,62
341Lectin Aﬃnity. As opposed to consecutively cutting glycan
342constituents, carbohydrate binding proteins, incorporated into
343the separation column, can result in speciﬁc peak retardation or
344disappearance, based upon their respective structural aﬃnity.
345Lectin aﬃnity CE enables the structural classiﬁcation of glycans
346by type (e.g., high-mannose51,62,63), antennary branching (e.g.,
347triantennary64,65), monosaccharide features (e.g., fucose,60,65,66
348bisecting GlcNAc,64 galactose,60 sialic acid65), or even by their
349glycosidic linkage type (e.g., α2−3 or 2−6 linked sialic
350acids60,67) via speciﬁc binding reactions. Similar to on-column
351enzymatic digestions, lectins can either be added to the
352BGE63−67 or introduced as a distinct zone,51,60,62 but generally
353no incubation time is needed. Although, not all lectin−
354carbohydrate interactions are well understood, binding
355associations are generally low and peak distortion can limit
356area based comparison of experiments with/without lectins,
357aﬃnity CE represents another fast and valuable structure
358identiﬁcation tool.
359Additional Separation Dimensions. Additional orthogo-
360nal separation dimensions oﬀering diﬀerent selectivity can
361drastically increase the resolution. Especially when investigating
362the identity of heterogeneous carbohydrate pools, the reduction
363of sample complexity by preparative separation and subsequent
364analysis of the collected fractions by CE is often indispensable.
365Analytes can either be partitioned into groups of multiple
366species according to sample properties such as charge state, or,
367often by using several preparative techniques, into distinct
368glycan species. The preparation of such puriﬁed carbohydrate
369standards enables the identiﬁcation strategies outlined under
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370 Oligosaccharide Standards and Enzymatic Digests, when
371 combined with exoglycosidase digestion. For highly complex
372 samples consisting of a multitude of species, this approach can
373 be extremely labor-intensive or even impossible due to
374 restricted sample availability and resolution limitations of
375 preparative techniques in separating closely related structures.
376 Diﬃculties in structural identiﬁcation arising from comigration
377 of species with similar charge to mass (or equivalent
378 hydrodynamic volume) ratios in CE can be minimized by
379 molecular charge or size based fractionation. Orthogonal
380 separation mechanisms, such as analyte polarity based surface
381 interaction, can also distinguish previously comigrating species,
382 due to diﬀerential separation selectivity.
383 Chromatographic techniques with various stationary phases
384 and corresponding distinct selectivities accompanied by higher
385 associated injection volume requirements are ideally suited for
386 preparative fractionation prior to CE analysis. Compatibility
387 with subsequent CE analysis is reached by desalting or the
388 application of volatile liquid phases. Similar to glycan analysis
389 by CE, sensitive detection in liquid chromatographic (LC)
390 techniques often requires the introduction of ﬂuorescent dyes.
391 However, on the basis of the diﬀerent selectivity of chromato-
392 graphic phases, diﬃculties can arise from certain properties of
393 labeling agents (e.g., charge, polarity) which were optimized for
394 glycan separation by CE. The combined application of
395 preparative LC and analytical CE techniques with sensitive
396 detection thus generally requires a compromise.
397 Anion-exchange chromatography (AEC) fractionation is one
398 of the popular means to separate glycan pools by their degree
399 of sialylation or other charge inducing modiﬁcation (e.g.,
400 phosphorylation). Each charged fraction may contain several
401 glycan structures, diﬀering, e.g., in branching degree,
402 composition of monosaccharides, and their position or linkage
403 but all exhibiting the respective equal net negative charge. In
404 CZE under arheic conditions, for example, comigration of
405 larger structures holding higher charge states with smaller
406 analytes, can aggravate structural identiﬁcation. Additional
407 charges introduced by sialic acids can be removed via sialidase
408 digestion and the resulting changes in relative peak areas
409 monitored, as outlined under Enzymatic Digests. In cases
410 where the ratio of charged vs neutral species is particularly
411 unbalanced in favor of the latter, e.g., sialo- vs asialo-glycans on
412 human IgG, and only trace amounts of certain charged species
413 are observed, exoglycosidase digestion induced increase of the
414 corresponding neutral species can be marginal. Partitioning into
415 charged fractions resolves overlaps between diﬀerentially
416 charged species and enables the monitoring of peak shifts to
417 unoccupied regions upon charge removal and direct compar-
418 ison to the associated neutral fraction.53
f2 419 Figure 2 shows the high pH high performance AEC
420 (HPAEC) fractionation and consecutive CE analyses of
421 human serum N-glycans released via endo H. While sialidase
422 digest of the total pool in trace BS could result in inconclusive
423 changes of the corresponding neutral species, individual
424 analysis of preparatively captured fractions and their sialidase
425 digestions revealed the identity of the underlying monosialy-
426 lated hybrid type species, as presented in Figure 2B.57
427 Highly charged labeling agents, such as the commonly used
428 8-aminopyrene-1,3,6-trisulphonic acid (APTS), can critically
429 increase the total negative charge of analytes, thus potentially
430 causing excessive retention on AEC phases. Moreover, the
431 fundamental separation principle in AEC is based upon
432 diﬀerences in charge distribution across the hydrated molecule.
433The subdivision into distant non- and reducing terminal
434charges further complicates the application of highly charged
435dyes for AEC-based fractionation. Using APTS as an ionic dye
436for CE separation and sensitive detection is still possible if
437fractionation is carried out using underivatized glycans and only
438subsequent dye conjugation. This was demonstrated by either
439blind fraction collection adhering to pre-established retention
440time windows from the separation of 2-aminobenzamide
441labeled glycans53 or pulsed amperometric detection (PAD)
442following HPAEC separation.57 On the basis of its separation
443principle, AEC allowed for additional size-based separation
444within each charged fraction, when operated with ﬂuorescently
445labeled glycans and sensitive optical detection.68 Supplemental
446size-based fraction collection of underivatized glycans was also
447achieved by UV detection69,70 or by HPAEC-PAD, which
448enabled sensitive elution monitoring at maintaining adequate
449resolution, as exemplarily shown in Figure 2A. HPAEC-based
450separation generally requires a subsequent buﬀer exchange step
451due to nonvolatile strongly alkaline mobile phases, the
452described associated ionic strength mismatch issues in CE
453separation, and high pH-induced sample epimerization.71
454Hydrophilic interaction liquid chromatographyis a high
455resolution fractionation alternative to AEC, also oﬀering
456orthogonal selectivity. Depending on the chromatographic
457column, retention is a function of hydrophilicity and associated
458glycan size or a combination with ionic interactions,72 when
Figure 2. (A) HPAEC-PAD proﬁle of human serum N-glycans
released via endo H. Areas subjected to fraction collection are
indicated. (B) CE-laser induced ﬂuorescence detection (LIF) trace of
APTS labeled total glycan pool from blood serum (BS), collected
fractions H3, H4 and their respective sialidase digests (H3 desial, H4
desial). Glycan symbols as in Figure 1. Adapted with permission from
ref 57. Copyright 2011 John Wiley & Sons, Inc.
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459 using amide- or amine-based stationary phases, respectively.
460 HILIC-based separation enables the collection of fractions with
461 high individual structure purity as opposed to common analyte
462 property based grouping in AEC; however, the higher
463 resolution of the HILIC fractionation results in an increased
464 number of fractions and associated larger scale downstream
465 analysis. Combination of HILIC fractionation and exoglycosi-
466 dase digestion of puriﬁed analytes is also commonly applied for
467 accurate glycan structural elucidation.73−75
468 Similar to AEC, the application of polar and ionic labeling
469 agents, such as APTS (log P −1.21) for CE analysis, was
470 preceded by either intact or removed charged glycan
471 constituents, using underivatized35 or APTS labeled oligosac-
472 charides,43,74 respectively. The motivations for these distinct
473 strategies, however, seem to originate from mass spectrometric
474 detection and CE instrument compatibility considerations.
475 Other ﬂuorescent labeling agents, such as 2-aminobenzoic acid,
476 (log P 0.78) featuring lower charge and polarity, were
477 successfully applied for both HILIC-based fractionation and
478 CE analysis using high sensitivity ﬂuorescence detection.73,76
479 Applications of reverse phase (RP) and size-exclusion
480 chromatography (SEC) glycan fractionation are limited due
481 to lower associated applicability and selectivity, respectively,
482 when compared to HILIC and generally low eﬃciency for
483 relatively small sugars (0.1−5 kDa range), respectively. Only
484 few high performance columns serving ranges in the low
485 molecular weight region exist,77 and exclusive size-based
486 preparative partitioning on ion-exchange columns suﬀers from
487 low resolution.78 As opposed to HILIC, retention on RP
488 stationary phases is based on hydrophobicity thus providing
489 only weak interaction for polar glycans. Although, type based
490 separation of high mannose, complex and fucosylated complex
491 glycans can be achieved,79 and RP-based fractionation could
492 resolve comigration of species from the distinct groups.80 Also
493 the derivatization with more hydrophobic dyes, such as 2-
494aminoacridone (log P 2.95), can facilitate RP fractionation
495potential.81
496Capillary electrophoresis can also be operated in preparative
497mode using larger capillary diameters and several interchange-
498able outlet buﬀer reservoirs for fraction collection.82 Low
499injection plug volumes often require several iterations of the
500fractionation process to achieve a suﬃcient amount of analyte
501per collected fraction.83 Micropreparative CE has nevertheless
502been successfully applied for oﬀ-line MALDI ionization and
503hyphenated mass detection, where higher concentration is
504reached by liquid phase evaporation and concentration within
505the MALDI matrix.84,85
506One often perceived limitation of CE is the low sample
507injection volume. However, this facilitates experiment repeti-
508tion and also the consecutive execution of diﬀerent CE
509separation modes. Hence, the simpliﬁcation of complex samples
510via elaborate preparative fractionation can be avoided by the
511introduction of additional analytical separation modes with
512diﬀerent selectivity. Glycans comigrating in one separation
513dimension can be separated in another with appropriate
514selectivity and vice versa. Such multidimensional mapping of
515oligosaccharides originates from the application of diﬀerent
516stationary phases for liquid chromatography.86 Nanoliter
517injection volumes and the versatility of CE allow the facile
518operation of several diﬀerent separation modes, including EOF
519and on-column complexation phenomena, on the same
520instrument or even capillary, by simple changing the electrolyte
521used. Normalized migration times of identiﬁed carbohydrate
522species from each separation dimension span a multidimen-
523sional database thus facilitating structural identiﬁcation of
524unknowns at increasing conﬁdence.87,88
525Combination of analytical CE and LC glycan separation
526methods comes at costs of additional instrumentation and
527sample preparation steps, e.g., introduced by diﬀerent
528ﬂuorescent labels optimized for each technique, but enables
Figure 3. Comprehensive annotation of the UPLC−ﬂuorescence and CE−LIF proﬁles of the N-glycans released from human serum polyclonal IgG
using a combination of exoglycosidase digestion and weak anion exchange fractionation. Insets show a table of the experimentally determined GU
value for each glycan structure and a comparative 2D plot. N-Glycan nomenclature from ref 91. Reprinted from ref 53. Copyright 2011 American
Chemical Society.
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529 orthogonal glycan separation.53,75 Although, ﬂuorescent dyes
530 suitable for both platforms have been presented,73,76,89,90
531 instrumental limitations such as available detection method,
532 can restrict their application. Disregarding the increased
533 necessary sample handling, the application of two distinct
534 analysis routes allows for monitoring potential experimental
535 discrepancies originating from, e.g., loss of labile glycan
536 constituents or salt content. Also one might not want to
537 change a certain analysis route due to already existing databases
538 that can be used for peak identiﬁcation in the other
539 dimension.69
f3 540 Figure 3 depicts the comprehensive annotation of the human
541 IgG N-glycan pool separated in both ultrahigh pressure LC
542 (UPLC)-HILIC and CE−LIF. Exhaustive glycan identiﬁcation
543 was achieved by the combined application of preparative anion
544 exchange fractionation and exoglycosidase digestion steps
545requiring over 48 h of total analysis time. In a two-dimensional
546plot, inset in Figure 3, all 32 oligosaccharides present were well
547separated and revealed clustering based upon their degree of
548sialylation. Combining high experimental precision, granted by
549the use of glucose unit values following time based normal-
550ization, with the beneﬁcial orthogonality of the separation
551platforms allowed for exhaustive and conﬁdent structural
552annotation of the IgG N-glycan pool within only 20 min of
553using the 2D space and made additional fractionation or
554digestion techniques obsolete.
555CE−MS: Molecular Mass and Fragmentation. Mass
556spectrometry oﬀers an information-rich complementary
557detection method for glycan analysis, facilitating the measure-
558ment of distinct analyte mass and charge properties when used
559online, independent from standard coinjection or exoglycosi-
560dase digest patterns. Glycan composition can be estimated
Figure 4. CE−MS/MS BPE of the ﬁxed m/z 555.7 in Q1 of a quadrupole ion trap MS (A) and MS/MS fragmentation spectra of the respective
peaks at 10.5 (B) and 10.9 min (C). The peak at 9.5 min corresponds to Man5GlcNAc2 at m/z 557.8. P, precursor ion. Fragmentation nomenclature
as in ref 93. Reprinted with permission from ref 102. Copyright 2007 Oxford University Press.
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561 based upon the addition of monosaccharide constituent masses.
562 However, because of the high structural diversity, numerous
563 combinations can result in equal mass values. Moreover, on the
564 monosaccharide level stereosiomers (e.g., glucose and man-
565 nose) exhibit the same masses, thus MS can only detect
566 diﬀerent classes of sugars such as hexose (glucose, galactose,
567 mannose), N-acetylhexosamine (GlcNAc or GalNAc), deoxy-
568 hexose (fucose), or sialic acids. Information about the identity
569 of monosaccharides may be deduced from additional sample
570 information such as glycan class (e.g., N-, O-glycan), taxonomy,
571 and associated biosynthetic pathways. Such information, if
572 available, provides very limited potential of elucidating linkage
573 and positional isobaric isomers. Therefore to increase the
574 overall level of information in each associated experiment, MS
575 detection can be combined with monosaccharide sequencing by
576 exoglycosidase digest induced mass shift monitoring or more
577 commonly the application of tandem mass spectrometry (MS/
578 MS) following collision induced dissociation (CID).92 In
579 tandem MS or higher order MSn approaches of pseudomo-
580 lecular oligosaccharide cations formed during positive ioniza-
581 tion, glycans ﬁrst break at their most labile bonds resulting in a
582 series of glycosidic cleavages. Glycosidic linkage cleavage allows
583 determination of monosaccharide sequence and branching
584 degree, based on B/Y or C/Z-ion series if negative ionization is
585 used,93 whereas cross-ring cleavages and associated A/X-ions
586 allow deduction of linkage positions.92 Because of the
587 complexity and potential interpretation ambiguity, it is often
588 reasonable to investigate fragmentation patterns with puriﬁed
589 glycan standards similar to those under study. However,
590 informatics platforms such as GlycoWorkBench94 and Glyco-
591 PeakFinder95 have greatly helped in simplifying the inter-
592 pretation of oligosaccharide MS/MS spectra.
593 Problems arise from direct infusion of complex sample
594 mixtures, where selected precursor ion masses potentially
595 contain structural isomers. Fragmentation of multiple species
596 can lead to incorrect spectral interpretation and glycan mass
597 based structural conclusions. Hyphenation of MS with
598 separation based techniques can provide additional structural
599 information or even resolve isomeric species and thus prevent
600 erroneous structural interpretation from the resulting spectral
601 data. Concentration of complex analyte pools into distinct
602 bands using separation techniques results in increased dynamic
603 range and associated sensitivity for MS detection. Furthermore,
604 less analyte will enter the MS together and thereby reduce the
605 suppression of less abundant ions by predominant ones. Ion
606 suppression eﬀects as well as biased quantitation of diﬀer-
607 entially charged analytes and associated ionization yield can be
608 resolved by upstream CE separation due to the inherently high
609 eﬃciency of CE based separations.
610 MS interfacing generally comes at the compromise in CE
611 resolution, introduced by a MS friendly BGE, the missing outlet
612 buﬀer reservoir, diﬀerential ionization interface gas pressure,
613 siphoning eﬀects, and band broadening in longer capillaries. On
614 the other hand, the more informative MS detection facilitates
615 the detection of comigrating nonisobaric analytes. High-
616 resolution oﬀ-line CE glycan separation with photometric
617 detection can be altered stepwise toward MS compatible
618 conditions. On the basis of relative abundances, respective
619 peaks can be assigned in the CE−MS base peak electrophero-
620 gram (BPE) and previously gathered structural information
621 matched or even amended.71,96,97 The more accurate
622 quantitation achieved by optical detection of heterogeneous
623analyte pools can also be incorporated online proximal to the
624mass spectrometer.98−100
625The separation of uncharged glycans in CE is problematic
626because on-column complexation with borate or metal ions is
627generally not MS compatible and sole EOF based separation
628lacks selectivity. Isocratic elution in CEC21,101 or the
629introduction of ionic labeling agents enable the parallel
630separation of both neutral and charged species. Labels are
631chosen not only based on CE separation optimization but also
632MS ionization considerations. Neutral or positively charged
633labeling agents, such as 9-ﬂuorenylmethyl and 3-aminopyrazole,
634are used for positive MS ionization polarity modes12,102 and
635vice versa for the more commonly used APTS, 8-amino-
636naphtalene-1,3,6-trisulfonic acid and 2-aminobenzoic acid in
637the negative mode.90,103,104
638 f4Figure 4A shows the CE−MS BPE of APTS labeled N-
639glycans from the structural subunit 1 of Rapana venosa
640hemocyanin at m/z 555.7 isolated in Q1 of a quadrupole ion
641trap MS.102 Counter-EOF conditions with the MS at the
642cathodic side allowed separation based on increasing negative
643charge and larger species migrating prior to smaller ones within
644each charged group. The peak at 9.5 min corresponded to the
645labeled Man5GlcNAc2 structure, whereas peaks at 10.5 and 10.9
646min represent isomers of a diﬀerent glycan species with an
647additional negative charge. Similar tandem MS spectra of the
648peaks at 10.5 and 10.9, depicted in respective parts B and C of
649Figure 4, endorsed matching the monosaccharide sequence and
650suggested the presence of positional isomers that were
651separated due to the high resolving power of CE.
652Labeling at the reducing end can provide valuable
653information on the site-attachment of speciﬁc glycan
654constituents due to fragment ions either including or lacking
655the mass and charge introduced by the labeling agent. A- and X-
656type ions and associated linkage position elucidation, however,
657are generally low when the reducing end of glycans is occupied,
658because cross-ring fragmentation predominantly occurs at the
659proximal end.105
660Unlabeled glycans that carry charged constituents, such as
661sialic acids or phosphate residues, were well separated in
662counter-EOF CZE based upon their charge degree and
663molecular size.106−109 Such acidic glycans are most sensitively
664detected by negative ion MS, but positive mode allows
665quantitation of diﬀerentially charged species, i.e., glycan pools
666containing both positive and negative oligosaccharides, using,
667e.g., acidic mobile phases in CEC that can protonate sialic
668acids.101 Glycans with an unoccupied reducing end produce
669more informative MS/MS spectra due to higher abundance of
670A/X-ions, but reducing terminal mutarotation can increase
671sample complexity.21 MS/MS fragmentation analysis of glycans
672holding terminal sialic acids often leads to predominant B1 ions
673originating from the loss of such charged glycan constituents
674and lower amounts of more informative C-type fragments.110
675Chemical derivatization via amidation, methylation, or
676permethylation can stabilize sialic acids111 and thus provide
677greater structural elucidation potential in MS/MS fragmenta-
678tion,112 but coinciding charge neutralization and increased
679hydrophobicity limit their online CE−MS application. Oﬄine
680CE fraction collection and spotting on MALDI plates combines
681CE eﬃciency with less complex MS spectra originated from
682mostly singly charged ions.84,85,113 Low mass loading in CE
683limits chemical derivatization options of collected fractions.
684These derivatizations are generally recommended to prevent
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685 glycan degradation during the higher energy laser desorption/
686 ionization.114
687 ■ CONCLUDING REMARKS AND PERSPECTIVES
688 The pursuit of unraveling the glyco-puzzle progresses with the
689 evolution of high-resolution separation techniques. Capillary
690 electrophoresis represents a rapid and high-resolution separa-
691 tion tool, which after sequencing the human genome found one
692 of its prime applications in the analysis of complex
693 carbohydrate mixtures. The ability of separating both linkage
694 and positional isomeric species based on inherent molecular
695 shape diﬀerences, such as hydrodynamic volume, has rendered
696 CE indispensable for ﬁne structural analysis. The underlying
697 separation principle can easily be inﬂuenced by capillary surface
698 modiﬁcations, replacing the background electrolyte, special
699 buﬀer additives, or ionic labeling agents to meet sample speciﬁc
700 optimal separation conditions. Despite the versatility of CE, the
701 introduction of additional separation dimensions should be
702 considered necessary to aid elucidating the vast structural
703 heterogeneity of glycans. Moreover, a parallel analysis route,
704 introducing, e.g., alternative labeling chemistry or orthogonal
705 separation, can prove beneﬁcial for method validation and
706 obviating potential systematic bias. Application of comple-
707 mentary analytical approaches not only increases structural
708 identiﬁcation accuracy but eventually opens up new possibilities
709 for the establishment of a score-based conﬁdence system based
710 on data integration from the individual dimensions.
711 Sophisticated exoglycosidase digestion and mass spectro-
712 metric detection represent further powerful means to increase
713 structural elucidation conﬁdence. Hyphenation of CE with MS
714 remains technically challenging but facilitates both sensitive and
715 highly informative detection when combined with the resolving
716 power of CE. MS also enables sensitive detection of unlabeled
717 glycans thus excluding potential associated analyte deterioration
718 or selective functionalization. Several informatics-based en-
719 deavors are being pursued to assist and (semi-) automate the
720 demanding interpretation of glycan MS and MS/MS
721 fragmentation spectra.
722 Glycoinformatics tools to aid CE based glycan structure
723 elucidation still remain marginal. Extensive mapping databases
724 that enable structural inference from normalized detection
725 times of ﬂuorescently derivatized glycans currently exist only
726 for HPLC based techniques and complementary databases for
727 CE are necessitated. However, the immense structural diversity
728 of glycans, time-consuming experiments, and the limited
729 availability of glycan standards impede an exhaustive accumu-
730 lation of such data. As opposed to surface interaction based
731 separation techniques, glycan analysis results by CE could more
732 easily be predicted based on computed geometrical character-
733 istics and a plethora of structure database entries generated in
734 silico. The combination of the diﬀerent data resources will
735 improve the conﬁdence and quality of glycan structure
736 identiﬁcation, for instance by CE separation based structure
737 constraints for subsequent MS/MS spectra annotation. There-
738 fore, it is anticipated that developing novel glycoinformatics
739 tools will play an equally important role as high-resolution
740 separation techniques and sensitive detection methods in
741 further resolution of the glyco-puzzle.
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